Showing results (21-30 of 473) with videos related to

Sort By:
Pageof 48
Hereditary Cancer in Clinical Practice|March 21, 2021
Clinical implementation of an oncology-specific family health history risk assessment toolSi Ming Fung, R Ryanne Wu, Rachel A Myers, et al.
Hereditary Cancer in Clinical Practice|February 5, 2021
Clinical challenges in interpreting multiple pathogenic mutations in single patientsChrista Slaught, Elizabeth G Berry, Lindsay Bacik, et al.
Hereditary Cancer in Clinical Practice|February 10, 2021
Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphomaSaad Akhtar, M Shahzad Rauf, Amani Al-Kofide, et al.
Hereditary Cancer in Clinical Practice|September 9, 2022
Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysisOlga Caramelo, Cristina Silva, Francisco Caramelo, et al.
Hereditary Cancer in Clinical Practice|September 8, 2022
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingKyra Bokkers, Eveline M A Bleiker, Jacob P Hoogendam, et al.
Hereditary Cancer in Clinical Practice|September 2, 2025
Medullary breast cancer and germline BRCA1 mutations: a possible criterion for genetic testingAdriana I Apostol, David Lim, Steven A Narod
Hereditary Cancer in Clinical Practice|July 21, 2016
Syndromic gastrointestinal stromal tumorsRiccardo Ricci
Hereditary Cancer in Clinical Practice|August 29, 2021
Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluationsZahra Meshkani, Ali Aboutorabi, Najmeh Moradi, et al.
Hereditary Cancer in Clinical Practice|May 5, 2015
Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinomaEwout P Boesaard, Ingrid P Vogelaar, Peter Bult, et al.
Hereditary Cancer in Clinical Practice|August 17, 2021
Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participantsKrithika Murali, Tanya M Dwarte, Mehrdad Nikfarjam, et al.
Pageof 48